Additional Proxy Soliciting Materials (definitive) (defa14a)
June 08 2017 - 5:18PM
Edgar (US Regulatory)
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the
Registrant ☒ Filed by a Party other than the
Registrant ☐
Check the appropriate box:
|
|
|
|
|
☐
|
|
Preliminary Proxy Statement
|
|
|
|
|
☐
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
|
|
☐
|
|
Definitive Proxy Statement
|
|
|
|
|
☒
|
|
Definitive Additional Materials
|
|
|
|
|
☐
|
|
Soliciting Material Pursuant to § 240.14a-12
|
Proteostasis Therapeutics, Inc.
(Name of Registrant as Specified In
Its Charter)
(Name of Person(s) Filing Proxy
Statement if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box)
|
|
|
|
|
|
|
|
|
|
☒
|
|
No fee required.
|
|
|
|
|
☐
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
|
|
|
Title of each class of securities to which transaction applies:
|
|
|
|
Aggregate number of securities to which transaction applies:
|
|
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on
which the filing fee is calculated and state how it was determined):
|
|
|
|
Proposed maximum aggregate value of transaction:
|
|
|
|
Total fee paid:
|
|
|
|
|
☐
|
|
Fee paid previously with preliminary materials.
|
|
|
|
|
☐
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
|
|
|
|
|
|
|
Amount Previously Paid:
|
|
|
|
Form, Schedule or Registration Statement No.:
|
|
|
|
Filing Party:
|
|
|
|
Date Filed:
|
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to be held on
August 3, 2017 for Proteostasis Therapeutics, Inc.
This communication is not a form of voting and presents only an overview of the more complete proxy
materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting. To view the proxy statement, annual report, directions to the annual meeting
and voting instructions, go to
www.proxydocs.com/pti
. To submit your proxy while visiting this site, you will need the 12 digit control number in the box below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be
distributed by making them available on the Internet. We have chosen to use these procedures for our 2017 Annual Meeting and need YOUR
participation.
If you want to receive a paper or e-mail copy of the proxy materials, you must request one. There is no charge to you for requesting a copy. In order to receive a
paper package in time for our 2017 Annual Meeting, please make this request on or before July 21, 2017.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For a Convenient Way to VIEW Proxy Materials
|
|
|
|
|
–
and
–
|
|
|
|
VOTE Online go to:
www.proxydocs.com/pti
|
|
Proxy Materials Available to View or Receive:
Annual Report and Proxy Statement
Printed
materials may be requested by one of the following methods:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INTERNET
www.investorelections.com/pti
|
|
|
|
TELEPHONE
(866) 648-8133
|
|
|
|
*E-MAIL
paper@investorelections.com
|
|
|
|
|
|
You must use the 12 digit control number
located in the shaded gray box below.
|
|
*
|
|
If requesting material by e-mail, please send a blank e-mail with the 12 digit control number (located below) in the subject line. No other requests, instructions or other inquiries should be included with your e-mail
requesting material.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proteostasis Therapeutics, Inc. Notice of Annual Meeting
|
|
|
|
|
|
Meeting Type:
|
|
Annual Meeting
|
|
|
|
|
|
|
|
For holders as of:
|
|
June 9, 2017
|
|
|
|
|
|
|
|
Date:
|
|
Thursday, August 3, 2017
|
|
|
|
|
|
|
Time:
|
|
9:00 A.M. (Eastern Time)
|
|
|
|
|
|
|
Place:
|
|
MassBio, 300 Technology Square,
8
th
Floor, Collaboration Room,
Cambridge, MA 02139
|
|
The Board of Directors Recommends a Vote FOR each of
the director nominees listed in proposal 1 and FOR proposal 2.
|
|
|
|
|
1.
|
|
To elect the three nominees for director named below to hold office until the 2020 Annual Meeting of Stockholders.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nominees:
|
|
(01) Meenu Chhabra
|
|
|
|
|
|
|
|
|
|
|
|
(02) Helen M. Boudreau
|
|
|
|
|
|
|
|
|
|
|
|
(03) Jeffery W. Kelly, Ph.D.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.
|
|
To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending
December 31, 2017.
|
|
|
|
Note: To consider and act upon such other business as may properly come before the meeting or any adjournment thereof.
|
|
|
Vote In-Person Instructions:
While we encourage stockholders to vote by the means indicated above, a
stockholder is entitled to vote in person at the Annual Meeting. If you wish to vote your shares at the Annual Meeting, please register with the Inspector of Elections at the desk marked “Stockholder Registration” at the entrance to
receive a ballot. Proper photo ID is required. Ballots should be returned to the Inspector of Elections in order to be counted. Additionally, a stockholder who has submitted a proxy before the meeting, may revoke that proxy in person at the Annual
Meeting.
Proteostasis Therapeutics (NASDAQ:PTI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Proteostasis Therapeutics (NASDAQ:PTI)
Historical Stock Chart
From Apr 2023 to Apr 2024
